EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HMGB3 promotes brain metastasis of lung adenocarcinoma by recruiting SSBP1 for nuclear translocation to remodel mitochondrial metabolism

Huanhuan Cui, Yuechao Yang, Sen Li, Yan Hao, Mingtao Feng, Changshuai Zhou, Xin Chen, Yang Gao, Lei Chen, Xiaojun Wu, Weiguo Hu, Liangdong Li und 1 weitere

Cancer Communications · 2025

DOI: 10.1002/cac2.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, 2025. Verfasst von Huanhuan Cui und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Brain Neoplasms, Adenocarcinoma of Lung, Lung Neoplasms, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Foundation of Shanghai Anticancer Association EYAS PROJECT, Beijing Xisike Clinical Oncology Research Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain metastasis, a leading cause of death in patients with lung adenocarcinoma (LUAD), arises from tumor cells adapting to the unique microenvironment of the brain through metabolic remodeling regulated by key oncogenes. Here, we aimed to determine the role of high mobility group protein box 3 (HMGB3) in regulating tumor cell metabolism to promote the progression and brain metastasis of LUAD.

Methods

A LUAD cell model predisposed to brain metastasis was established, followed by differential gene expression analysis. HMGB3 expression was quantified via single‐cell RNA sequencing (scRNA‐seq) and immunohistochemistry, with clinical relevance assessed in two retrospective cohorts: the primary LUAD and the LUAD brain metastasis cohorts. Gene enrichment analysis of scRNA‐seq and bulk RNA‐seq data, along with Western blotting, were performed to identify HMGB3‐associated pathways. Co‐immunoprecipitation combined with mass spectrometry was used to detect HMGB3‐interacting proteins. Gain‐of‐function, loss‐of‐function and rescue experiments targeting HMGB3 downstream pathways were conducted in vitro and in vivo.

Results

HMGB3 expression was significantly elevated in both primary LUAD lesions and brain metastatic foci, and its upregulation was strongly associated with poor prognosis in LUAD patients, as well as in those with concomitant brain metastasis. HMGB3 enhanced the migration, invasion, and epithelial‐mesenchymal transition (EMT) capabilities of LUAD cells in vitro and promoted the development of brain metastasis in vivo. Mechanistically, HMGB3 recruited and interacted with single‐stranded DNA‐binding protein 1 (SSBP1), inducing its nuclear translocation and reprogramming mitochondrial metabolism. This process elevated cytoplasmic reactive oxygen species levels, which subsequently activated the phosphatidylinositol 3‐kinase/protein kinase B (PI3K‐Akt) signaling pathway through downregulating phosphatase and tensin homolog (PTEN), ultimately promoting tumor cell proliferation, migration, invasion, and EMT.

Conclusions

This study demonstrated HMGB3 as a key regulator of the brain metastasis of LUAD, orchestrating tumor cells’ metabolic adaptation to the brain microenvironment through modulation of mitochondrial metabolism, thereby offering potential therapeutic targets for LUAD brain metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsAdenocarcinoma of LungLung NeoplasmsMitochondriaHMGB3 ProteinDNA-Binding ProteinsHumansAnimalsMiceCell Line, TumorFemaleMaleGene Expression Regulation, NeoplasticCell NucleusMice, NudeCell Movement

Stichwörter der Autor:innen

brain metastasishigh mobility group protein box 3lung adenocarcinomamitochondrial metabolismsingle‐stranded DNA‐binding protein 1

Substanzen

HMGB3 ProteinDNA-Binding Proteins

Autor:innen und Institutionen

  • Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.

ORCID-Profile: Yiqun Cao

Förderung

  • the Foundation of Shanghai Anticancer Association EYAS PROJECT
  • Beijing Xisike Clinical Oncology Research Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Cui, H., Yang, Y., Li, S., Hao, Y., Feng, M., Zhou, C., Chen, X., Gao, Y., Chen, L., Wu, X., Hu, W., Li, L., & Cao, Y. (2025). HMGB3 promotes brain metastasis of lung adenocarcinoma by recruiting SSBP1 for nuclear translocation to remodel mitochondrial metabolism. Cancer Communications. https://doi.org/10.1002/cac2.70075

Vancouver

Cui H, Yang Y, Li S, Hao Y, Feng M, Zhou C, et al. HMGB3 promotes brain metastasis of lung adenocarcinoma by recruiting SSBP1 for nuclear translocation to remodel mitochondrial metabolism. Cancer Communications. 2025. doi:10.1002/cac2.70075

BibTeX
@article{Cui2025,
  author = {Cui, Huanhuan and Yang, Yuechao and Li, Sen and Hao, Yan and Feng, Mingtao and Zhou, Changshuai and Chen, Xin and Gao, Yang and Chen, Lei and Wu, Xiaojun and Hu, Weiguo and Li, Liangdong and Cao, Yiqun},
  title = {HMGB3 promotes brain metastasis of lung adenocarcinoma by recruiting SSBP1 for nuclear translocation to remodel mitochondrial metabolism},
  journal = {Cancer Communications},
  year = {2025},
  doi = {10.1002/cac2.70075}
}
Kostenlos starten →